146 related articles for article (PubMed ID: 25938595)
1. Strategies to rescue the consequences of inducible arginase-1 deficiency in mice.
Ballantyne LL; Sin YY; St Amand T; Si J; Goossens S; Haenebalcke L; Haigh JJ; Kyriakopoulou L; Schulze A; Funk CD
PLoS One; 2015; 10(5):e0125967. PubMed ID: 25938595
[TBL] [Abstract][Full Text] [Related]
2. Liver-specific knockout of arginase-1 leads to a profound phenotype similar to inducible whole body arginase-1 deficiency.
Ballantyne LL; Sin YY; Al-Dirbashi OY; Li X; Hurlbut DJ; Funk CD
Mol Genet Metab Rep; 2016 Dec; 9():54-60. PubMed ID: 27761413
[TBL] [Abstract][Full Text] [Related]
3. Myocyte-mediated arginase expression controls hyperargininemia but not hyperammonemia in arginase-deficient mice.
Hu C; Kasten J; Park H; Bhargava R; Tai DS; Grody WW; Nguyen QG; Hauschka SD; Cederbaum SD; Lipshutz GS
Mol Ther; 2014 Oct; 22(10):1792-802. PubMed ID: 24888478
[TBL] [Abstract][Full Text] [Related]
4. Long-term survival of the juvenile lethal arginase-deficient mouse with AAV gene therapy.
Lee EK; Hu C; Bhargava R; Rozengurt N; Stout D; Grody WW; Cederbaum SD; Lipshutz GS
Mol Ther; 2012 Oct; 20(10):1844-51. PubMed ID: 22760543
[TBL] [Abstract][Full Text] [Related]
5. Lethal phenotype in conditional late-onset arginase 1 deficiency in the mouse.
Kasten J; Hu C; Bhargava R; Park H; Tai D; Byrne JA; Marescau B; De Deyn PP; Schlichting L; Grody WW; Cederbaum SD; Lipshutz GS
Mol Genet Metab; 2013 Nov; 110(3):222-30. PubMed ID: 23920045
[TBL] [Abstract][Full Text] [Related]
6. Inducible arginase 1 deficiency in mice leads to hyperargininemia and altered amino acid metabolism.
Sin YY; Ballantyne LL; Mukherjee K; St Amand T; Kyriakopoulou L; Schulze A; Funk CD
PLoS One; 2013; 8(11):e80001. PubMed ID: 24224027
[TBL] [Abstract][Full Text] [Related]
7. Minimal ureagenesis is necessary for survival in the murine model of hyperargininemia treated by AAV-based gene therapy.
Hu C; Tai DS; Park H; Cantero G; Cantero-Nieto G; Chan E; Yudkoff M; Cederbaum SD; Lipshutz GS
Gene Ther; 2015 Feb; 22(2):111-5. PubMed ID: 25474440
[TBL] [Abstract][Full Text] [Related]
8. Short-term correction of arginase deficiency in a neonatal murine model with a helper-dependent adenoviral vector.
Gau CL; Rosenblatt RA; Cerullo V; Lay FD; Dow AC; Livesay J; Brunetti-Pierri N; Lee B; Cederbaum SD; Grody WW; Lipshutz GS
Mol Ther; 2009 Jul; 17(7):1155-63. PubMed ID: 19367256
[TBL] [Abstract][Full Text] [Related]
9. Ornithine deficiency in the arginase double knockout mouse.
Deignan JL; Livesay JC; Yoo PK; Goodman SI; O'Brien WE; Iyer RK; Cederbaum SD; Grody WW
Mol Genet Metab; 2006; 89(1-2):87-96. PubMed ID: 16753325
[TBL] [Abstract][Full Text] [Related]
10. Arginase-1 deficiency.
Sin YY; Baron G; Schulze A; Funk CD
J Mol Med (Berl); 2015 Dec; 93(12):1287-96. PubMed ID: 26467175
[TBL] [Abstract][Full Text] [Related]
11. Rescue of the Functional Alterations of Motor Cortical Circuits in Arginase Deficiency by Neonatal Gene Therapy.
Cantero G; Liu XB; Mervis RF; Lazaro MT; Cederbaum SD; Golshani P; Lipshutz GS
J Neurosci; 2016 Jun; 36(25):6680-90. PubMed ID: 27335400
[TBL] [Abstract][Full Text] [Related]
12. Generation of a mouse model for arginase II deficiency by targeted disruption of the arginase II gene.
Shi O; Morris SM; Zoghbi H; Porter CW; O'Brien WE
Mol Cell Biol; 2001 Feb; 21(3):811-3. PubMed ID: 11154268
[TBL] [Abstract][Full Text] [Related]
13. Hyperargininemia due to liver arginase deficiency.
Crombez EA; Cederbaum SD
Mol Genet Metab; 2005 Mar; 84(3):243-51. PubMed ID: 15694174
[TBL] [Abstract][Full Text] [Related]
14. Mouse model for human arginase deficiency.
Iyer RK; Yoo PK; Kern RM; Rozengurt N; Tsoa R; O'Brien WE; Yu H; Grody WW; Cederbaum SD
Mol Cell Biol; 2002 Jul; 22(13):4491-8. PubMed ID: 12052859
[TBL] [Abstract][Full Text] [Related]
15. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
[TBL] [Abstract][Full Text] [Related]
16. Neonatal cholestasis: an uncommon presentation of hyperargininemia.
Gomes Martins E; Santos Silva E; Vilarinho S; Saudubray JM; Vilarinho L
J Inherit Metab Dis; 2010 Dec; 33 Suppl 3():S503-6. PubMed ID: 21229317
[TBL] [Abstract][Full Text] [Related]
17. Arginase I mRNA therapy - a novel approach to rescue arginase 1 enzyme deficiency.
Asrani KH; Cheng L; Cheng CJ; Subramanian RR
RNA Biol; 2018; 15(7):914-922. PubMed ID: 29923457
[TBL] [Abstract][Full Text] [Related]
18. Lipid nanoparticle-targeted mRNA therapy as a treatment for the inherited metabolic liver disorder arginase deficiency.
Truong B; Allegri G; Liu XB; Burke KE; Zhu X; Cederbaum SD; Häberle J; Martini PGV; Lipshutz GS
Proc Natl Acad Sci U S A; 2019 Oct; 116(42):21150-21159. PubMed ID: 31501335
[TBL] [Abstract][Full Text] [Related]
19. Proof-of-Concept Gene Editing for the Murine Model of Inducible Arginase-1 Deficiency.
Sin YY; Price PR; Ballantyne LL; Funk CD
Sci Rep; 2017 May; 7(1):2585. PubMed ID: 28566761
[TBL] [Abstract][Full Text] [Related]
20. Rapid and highly efficient inducible cardiac gene knockout in adult mice using AAV-mediated expression of Cre recombinase.
Werfel S; Jungmann A; Lehmann L; Ksienzyk J; Bekeredjian R; Kaya Z; Leuchs B; Nordheim A; Backs J; Engelhardt S; Katus HA; Müller OJ
Cardiovasc Res; 2014 Oct; 104(1):15-23. PubMed ID: 25082846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
